2023-06-20T18:30:19+00:00 2022-12-31 350921680 CROWE LLP 225 West Wacker Drive Suite 2600 Chicago IL 606061224 990 2022-01-01 273941186 The End Fund Inc ENDF 6466909775 2 Park Avenue 28th Floor New York NY 10016 HANNAH CHANG Senior Director Finance/Admin 6466909775 2023-06-20 true ELLEN AGLER 999009999 MALLORY FAIRLESS P01321579 3128997000 2022 2023-04-26 12:10:37Z X ELLEN AGLER 2 Park Avenue 28th Floor New York NY 10016 79135799 false X WWW.END.ORG X 2010 DE The END Fund's mission is to control and eliminate the most prevalent neglected tropical diseases. 8 8 46 8 0 0 35023313 79127640 0 10930 8159 0 35034243 79135799 26702131 44455635 0 6714845 9186858 0 2713472 3556362 6851124 36973338 60493617 -1939095 18642182 37486570 58581667 291990 2774513 37194580 55807154 The END Fund's mission is to control and eliminate the most prevalent neglected tropical diseases. false false 56109329 44455635 THE END FUND MANAGES A PORTFOLIO OF PHILANTHROPIC FUNDS TO CONTROL AND ELIMINATE THE MOST PREVALENT NEGLECTED TROPICAL DISEASES AS OPPORTUNITIES FOR PRIVATE PHILANTHROPISTS, FOUNDATIONS, CORPORATIONS, AND OTHERS. THE END FUND FOCUSES ON DELIVERING NEGLECTED TROPICAL DISEASE (NTD) TREATMENTS TO THOSE IN NEED BY GROWING AND ENGAGING A COMMUNITY OF ACTIVIST-PHILANTHROPISTS, MANAGING HIGH-IMPACT STRATEGIC INVESTMENTS, AND WORKING IN COLLABORATION WITH GOVERNMENT, NGO, PHARMACEUTICAL, AND ACADEMIC PARTNERS. WE AIM TO TAKE A SYSTEMS APPROACH TO UNDERSTANDING, ENGAGING WITH, AND INFLUENCING THE BROAD ECOSYSTEM OF STAKEHOLDERS WORKING ON ENDING NTDS. In close partnership with stakeholders across the global NTD community, the END Fund: Identifies gaps and opportunities - understands investment needs and gaps, landscapes investable opportunities, and increases coordination among stakeholders; Builds coalitions - mobilizes and activates collaboration among country-level stakeholders, including ministries of health, NGOs, donors, etc.; Designs programs - works with implementing partner NGOs to expand data collection, mapping, and sector knowledge in order to identify compelling program opportunities; Strengthens capacity - aims to grow and strengthen the pool of partner organizations to assist local governments in the implementation of quality NTD programs; Manages grants and provides technical support - conducts country program visits and provides partner support, technical assistance, and capacity building as needed; and Conducts monitoring, evaluation, and program communications - designs and executes monitoring, evaluation, and information sharing activities to inform program design, organizational decision making, and donor updates. In 2022, the END Fund supported the distribution of 277,557,535 NTD treatments with 194,031,334 people were treated across 17 countries by 20 implementing partners. During the same period, 27,161 surgeries were conducted in 9 countries by 11 implementing partners and 1,037,761 health care workers trained across 17 countries by 19 implementing partners. 56109329 true true false false false false false false false true false false true true true true false false false true true false false false false false true false true false false false false false false false false false false false false false true false false false true 30 0 true 46 true false false false false false false false false false false false false X 8 8 true false false false false false false true false false false true true true true true true true true false CA FL GA AL HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA AR WV WI X X HANNAH CHANG 6466909775 2 PARK AVENUE 28TH FLOOR NEW YORK NY 10016 ALAN MCCORMICK VICE CHAIR 1.0 X X 0 0 0 SCOTT POWELL TREASURER 1.0 X X 0 0 0 Tsitsi Masiyiwa VICE CHAIR 1.0 X X 0 0 0 WILLIAM CAMPBELL CHAIR 1.0 X X 0 0 0 CHRISTINE WACHTER CAMPBELL DIRECTOR 1.0 X 0 0 0 ENGLISH SALL DIRECTOR 1.0 X 0 0 0 MICHAEL HOFFMAN DIRECTOR 1.0 X 0 0 0 Moses Bockarie DIRECTOR 1.0 X 0 0 0 DIANA BENTON SCHECHTER VP STRATEGY & OPERATIONS/BOARD SECRETARY 40.0 X 310824 0 31752 ELLEN AGLER CHIEF EXECUTIVE OFFICER 40.0 X 436937 0 53669 ALLISON MORRIS VP INVESTOR RELATIONS 40.0 X 295255 0 46134 DANIEL DALEY VP FINANCE AND ADMINISTRATION 40.0 X 240992 0 16599 JAMIE TALLANT ASSOCIATE VICE PRESIDENT, PROGRAMS 40.0 X 205608 0 27396 KAREN PALACIO ASSOCIATE VICE PRESIDENT, PROGRAMS 40.0 X 196443 0 35518 SAMUEL MAYER VP PUBLIC AFFAIRS 40.0 X 234773 0 19463 1920832 0 230531 26 false true false Atlas Technology Solutions Inc 1331 F Street NW Suite 420 Washington DC 20004 Global Employer of Record 3453032 JPMorgan Chase 270 Park Ave 31st Floor New York NY 10017 Financial Services 989049 Real Useful Travel & Marketing Company AEE Building Karen Road Nairobi KE Travel, event meeting service 553004 Suwwah Al Alam Lil Siyaha Wal Safar (Global Tours DMC) 12 YAJUZ ROAD CARACAS COMPLEX Amman JO Travel, event meeting service 332310 GCI Health 3 Columbus Circle New York NY 10019 Advocacy consulting 246591 11 79127640 79127640 0 0 0 0 0 8159 8159 0 0 0 0 0 0 0 0 0 79135799 0 0 8159 13821779 13821779 30633856 30633856 833182 577715 78555 176912 6378165 4315555 812274 1250336 133003 53597 28204 51202 1083892 728556 142475 212861 758616 548052 91944 118620 22237 15382 2084 4771 103565 22545 81020 2505549 1855992 106140 543417 300278 291055 50 9173 160486 103658 33612 23216 209739 95896 82361 31482 465430 349086 38142 78202 1076565 906406 70423 99736 1855945 1745789 27155 83001 68595 41162 14260 13173 61925 61925 Fundraising Platform Fees 15495 15495 Subscriptions 5315 3248 192 1875 0 0 0 0 60493617 56109329 1670816 2713472 29955338 49709468 2189420 2505060 4442289 2624518 0 0 467347 483339 340744 306010 80659 34734 0 0 351517 3224548 37486570 58581667 239956 251357 0 52034 2523156 291990 2774513 X 4806747 1517676 32387833 54289478 37194580 55807154 37486570 58581667 X 18642182 -29608 X false true X true false X 3262863 12287111 12003675 15492363 16646973 59692985 0 0 3262863 12287111 12003675 15492363 16646973 59692985 23934995 35757990 2086 33859 130880 10930 8159 185914 0 0 0 0 0 0 0 59878899 0 0.5972 0.6206 X Schedule A, Part II, Line 1 Unusual Grants 2022 - $62,480,667 2021 - $19,530,950 2020 - $10,652,528 2019- $32,657,784 2018- $23,674,556 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 135610 106449 29161 133199 134362 -1163 71935 65199 6736 34734 Right of Use Asset 2379350 Receivable - Due from UK 845198 3224548 0 Lease Liability 2523156 2523156 X 79135799 0 0 79135799 0 0 79135799 60523225 29608 0 29608 60493617 0 0 60493617 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote Accounting principles generally accepted in the United States of America prescribe requirements for the recognition of income taxes in the financial statements, and the amounts recognized are affected by income tax positions taken by the Organization in its tax returns. The END Fund, Inc. (U.S.) is exempt from Federal income taxes under Section 501(c)(3) of the Internal Revenue Code. The Organization's status as an exempt organization is defined as an income tax position under these requirements. While management believes it has complied with the Internal Revenue Code, the sustainability of some income tax positions taken by the Organization in its tax returns may be uncertain. There are minimum thresholds of likelihood that uncertain tax positions are required to meet before being recognized in the financial statements. Management does not believe that the Organization Fund has any material uncertain tax positions at December 31, 2021 and 2020. Accordingly, no provision or liability for income taxes has been recorded in the financial statements. In addition, the Organization has no income tax related penalties or interest for the periods reported in these financial statements. In the event that interest and penalties were due relating to an unsustainable tax position, they would be treated as a component of income tax expense. true South Asia 0 0 Grantmaking NTDs 272493 Sub-Saharan Africa 0 0 Grantmaking NTDs 29922232 Middle East and North Africa 0 0 Grantmaking NTDs 936750 0 0 0 0 0 0 31131475 0 31131475 Middle East and North Africa NTDS 936750 WIRE 0 N/A N/A South Asia NTDS 272493 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 7348 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 714309 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 58267 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 922503 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 4221908 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 441032 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 7994 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 3824139 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 1377555 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 141238 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 6706869 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 719036 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 630624 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 36134 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 145879 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 192574 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 46000 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 230900 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 97765 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 1279377 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 26071 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 296098 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 1664502 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 758472 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 733896 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 178724 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 253554 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 276773 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 62635 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 2355850 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 63125 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 564318 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 400000 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 19144 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 9885 WIRE 0 N/A N/A Sub-Saharan Africa NTDS 457734 WIRE 0 N/A N/A 35 3 false false false false false true Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds THE END FUND HAS A ROBUST GRANT AND PROJECT MANAGEMENT PROCESS SINCE THIS IS THE PRIMARY PROGRAMMATIC WORK THE ORGANIZATION UNDERTAKES. GRANT MANAGEMENT INCLUDES IN-PERSON MEETINGS WITH GRANT RECIPIENTS, DUE DILIGENCE ON THEIR PROJECT, DOCUMENTATION ENCAPSULATED IN A COMPREHENSIVE GRANT AGREEMENT, REGULAR REPORTING INCLUDING CURRENT RESOURCE ANALYSIS AND FUTURE GRANT REQUESTS. UPON COMPLETION OF A PROJECT THE ORGANIZATION UNDERTAKES A CRITICAL REVIEW OF THE GRANT TO GLEAN LESSONS LEARNED FOR USE IN FUTURE PROJECTS. DOCUMENTATION USED IN GRANTMAKING INCLUDE AN APPLICATION FORM WITH A PERFORMANCE ASSESSMENT FRAMEWORK, A PROPOSED BUDGET AND CASH FLOW FROM THE GRANTEE, RISK SCORING, THE PREVIOUSLY MENTIONED GRANT AGREEMENT, REPORTING TEMPLATES FOR FINANCIAL AND NARRATIVE SECTIONS, AND WRITTEN REPORTS FOLLOWING FIELD VISITS AND INSPECTIONS. THE ORGANIZATION PROGRAM STAFF MEETS IN PERSON WITH THE GRANT RECIPIENT'S TEAM AND DISCUSSED PLANNED OUTCOMES, WORK DETAILS, PROCESSES AND REPORTING. ALL WRITTEN GRANTMAKING MATERIALS ARE RETAINED CENTRALLY FOR ARCHIVAL PURPOSES. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements MIDDLE EAST AND NORTH AFRICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements MIDDLE EAST AND NORTH AFRICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual true Akros Inc 4302 Timberlane Missoula MT 59802 263668995 Corporation 296983 0 FM N/A N/A Dimagi Inc 585 Massachusetts Ave Suite 3 Cambridge MA 02139 830343298 Corporation 125588 0 FM N/A N/A Evidence Action Inc 1875 K Street NW 4th Floor Washington DC 20016 900874591 501(c)(3) 620039 0 FM N/A N/A FHI 360 359 Blackwell Street Suite 200 Durham NC 27701 237413005 501(c)(3) 409824 0 FM N/A N/A Helen Keller International One Dag Hammarskjold Plaza New York NY 10017 135562162 501(c)(3) 1175596 0 FM N/A N/A IMA WORLD HEALTH 1730 M STREET NW SUITE 1100 WASHINGTON DC 20036 522112460 501(c)(3) 880575 0 FM N/A N/A Orbis International 520 8th Avenue 12th Floor New York NY 10018 237297651 501(c)(3) 827725 0 FM N/A N/A The Carter Center Inc 520 8th Avenue 12th Floor New York NY 10018 237297651 501(c)(3) 5894214 0 FM N/A N/A United Front Against Riverblindness 13 Carnation Place Lawrenceville NJ 08648 364551151 501(c)(3) 2088268 0 FM N/A N/A 7 2 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. THE END FUND HAS A ROBUST GRANT AND PROJECT MANAGEMENT PROCESS SINCE THIS IS THE PRIMARY PROGRAMMATIC WORK THE ORGANIZATION UNDERTAKES. GRANT MANAGEMENT INCLUDES IN-PERSON MEETINGS WITH GRANT RECIPIENTS, DUE DILIGENCE ON THEIR PROJECT, DOCUMENTATION ENCAPSULATED IN A COMPREHENSIVE GRANT AGREEMENT, REGULAR REPORTING INCLUDING CURRENT RESOURCE ANALYSIS AND FUTURE GRANT REQUESTS. UPON COMPLETION OF A PROJECT THE ORGANIZATION UNDERTAKES A CRITICAL REVIEW OF THE GRANT TO GLEAN LESSONS LEARNED FOR USE IN FUTURE PROJECTS. DOCUMENTATION USED IN GRANTMAKING INCLUDE AN APPLICATION FORM WITH A PERFORMANCE ASSESSMENT FRAMEWORK, A PROPOSED BUDGET AND CASH FLOW FROM THE GRANTEE, RISK SCORING, THE PREVIOUSLY MENTIONED GRANT AGREEMENT, REPORTING TEMPLATES FOR FINANCIAL AND NARRATIVE SECTIONS, AND WRITTEN REPORTS FOLLOWING FIELD VISITS AND INSPECTIONS. THE ORGANIZATION PROGRAM STAFF MEETINGS IN PERSON WITH THE GRANT RECIPIENT'S TEAM AND DISCUSSES PLANNED OUTCOMES, WORK DETAILS, PROCESSES AND REPORTING. ALL WRITTEN GRANTMAKING MATERIALS ARE RETAINED CENTRALLY FOR ARCHIVAL PURPOSES. X X X X X false false false false false false false false false DIANA BENTON SCHECHTER VP STRATEGY & OPERATIONS/BOARD SECRETARY 310824 0 0 0 0 0 14383 0 17369 0 342576 0 0 0 ELLEN AGLER CHIEF EXECUTIVE OFFICER 395937 0 41000 0 0 0 15250 0 38419 0 490606 0 0 0 ALLISON MORRIS VP INVESTOR RELATIONS 295255 0 0 0 0 0 9767 0 36367 0 341389 0 0 0 DANIEL DALEY VP FINANCE AND ADMINISTRATION 240992 0 0 0 0 0 6422 0 10177 0 257591 0 0 0 JAMIE TALLANT ASSOCIATE VICE PRESIDENT, PROGRAMS 205608 0 0 0 0 0 9234 0 18162 0 233004 0 0 0 KAREN PALACIO ASSOCIATE VICE PRESIDENT, PROGRAMS 196443 0 0 0 0 0 9234 0 26284 0 231961 0 0 0 SAMUEL MAYER VP PUBLIC AFFAIRS 234773 0 0 0 0 0 0 0 19463 0 254236 0 0 0 Form 990, Part VI, Line 2 Family/business relationships amongst interested persons DIRECTORS WILLIAM CAMPBELL AND CHRISTINE WACHTER CAMPBELL - Family relationship Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing body There is no such committee with authority to act on behalf of the governing body. Therefore this question has been checked no. Form 990, Part VI, Line 11b Review of form 990 by governing body THE FORM 990 IS PREPARED BY MANAGEMENT IN CONJUNCTION WITH THE EXTERNAL TAX PREPARERS OF THE ORGANIZATION. WHEN SUBSTANTIALLY COMPLETE IT IS SENT ELECTRONICALLY TO THE BOARD OF DIRECTORS FOR A REVIEW and is presented at the board meeting BEFORE IT IS FINALIZED AND FILED WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy THE ORGANIZATION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY THAT INCLUDES A DEFINITION OF WHAT CONFLICT OF INTEREST MEANS, PROCESSES TO NOTIFY RELEVANT PARTIES, PROCEDURES TO RECUSE CONFLICTED INDIVIDUALS, AND ACTION NEEDED TO DOCUMENT THE STEPS THAT WERE TAKEN. EACH BOARD MEMBER AND STAFF IS REQUIRED TO COMPLETE AN ANNUAL CONFLICT OF INTEREST STATEMENT. THE SIGNED STATEMENTS ARE REVIEWED AND RETAINED BY MANAGEMENT. In accordance with the organization's conflict of interest policy, any actual or perceived conflicts of interest identified are addressed by the board to determine if corrective or restrictive action, intended to protect the organization's interest, is needed. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE END FUND HAS A POLICY IN PLACE TO EVALUATE THE PERFORMANCE AND THE COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. THE BOARD CONSIDERS SIMILAR NONPROFIT ORGANIZATIONS IN BENCHMARKING AGAINST A PEER GROUP, LOOKS AT PERFORMANCE OF THE CEO, AND RECOMMENDS A SALARY AND POSSIBLY A BONUS AMOUNT FOR THE PERIOD UNDER REVIEW. A DIALOGUE IS FACILITATED WITH THE CEO AT EACH STAGE OF THE REVIEW PROCESS. ANY ADJUSTMENTS TO COMPENSATION ARE APPROVED BY THE FULL BOARD. THE CEO IS NOT PRESENT DURING THIS STAGE OF THE BOARD DELIBERATIONS AND APPROVALS. The deliberations and decisions regarding the review and approval of the CEO's compensation are documented in the minutes to board of directors meeting. The board of directors reviews and approves the CEO's compensation on an annual basis. This process was last done in 2022. Form 990, Part VI, Line 15b Process to establish compensation of other employees The compensation for the Senior VP Strategy & Operations is reviewed and approved by the organization's board of directors. In determining compensation, the organization engages an external compensation consultant to conduct extensive benchmarking research and provide comparability data. The deliberations regarding the determination of compensation took place during the executive session and the decision with regards to compensation was documented. The process for determining compensation is performed on an annual basis. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION POSTS ITS AUDITED FINANCIAL STATEMENTS AND THE PUBLIC DISCLOSURE COPY OF THE FORM 990 ON ITS WEBSITE AT WWW.END.ORG. THE FORM 990 IS ALSO AVAILABLE AT WWW.GUIDESTAR.COM. GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND THE FORM 1023 IS AVAILABLE TO THE PUBLIC UPON REQUEST, SUBMITTED BY MAIL, TELEPHONE OR EMAIL. Form 990, Part XI, Line 9 Other changes in net assets or fund balances FX Loss - -29608; THE END FUND LIMITED CHARITY UK 501(c)(3) 7 NA false false false false true false false false false false false false false false false true false true false false